Editorial: Recommendations regarding the use of methylprednisolone in acute spinal cord injury: Making sense out of the controversy

Spine

Volumn 26, Issue 24 SUPPL., 2001, Pages

  Fehlings, M G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE;

ACUTE DISEASE; CELL DAMAGE; CELL DEATH; DISEASE ASSOCIATION; EDITORIAL; HUMAN; ISCHEMIA; NEUROPROTECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SPINAL CORD INJURY; TREATMENT PLANNING;

EID: 0035893642     PISSN: 03622436     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007632-200112151-00012     Document Type: Editorial

References (21)

1. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-Year follow-up data. Results of the Second National Acute Spinal Cord Injury Study
2. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury: Results of the Second National Acute Spinal Cord Injury Study
3. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury: Results of the Third National Acute Spinal Cord Injury randomized controlled trial. National Acute Spinal Cord Injury Study
4. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-Year follow up. Results of the Third National Acute Spinal Cord Injury randomized controlled trial
5. Methylprednisolone and acute spinal cord injury: An update of the randomized evidence
6. Establishing prognosis and maximizing functional outcomes after spinal cord injury: A review of current and future directions ni rehabilitation management
7. Methylprednisolone administration improves axonal regeneration into Schwann cell grafts in transected adult rat thoracic spinal cord
8. A critical appraisal of the reporting of the National Acute Spinal Cord Injury Studies (II and III) of methylprednisolone in acute spinal cord injury
9. Spinal cord injury: Role of steroid therapy
10. The Sygen® multicenter acute spinal injury study
11. The neuroprotective pharmacology of methylprednisolone
12. Lack of effect of postinjury treatment with methylprednisolone or tirilazad mesylate on the increase in eicosanoid levels in the acutely injured cat spinal cord
13. Methylprednisolone for acute spinal cord injury: An inappropriate standard of care
14. Steroids and spinal cord injury: Revisiting the NASCIS 2 and NASCIS 3 trials
15. Calpeptin and methylprednisolone inhibit apoptosis in rat spinal cord injury
16. Effect of nimodipine or methylprednisolone on recovery from acute experimental spinal cord injury in rats
17. Epidemiology, demographics, and pathophysiology of acute spinal cord injury
18. High dose methylprednisolone in the management of acute spinal cord injury: A systematic review from a clinical perspective
19. Assessing the clinical effectiveness of preventive maneuvers: Analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations
20. Methylprednisolone inhibition of TNF-alpha expression and NF-kB activation after spinal cord injury in rats
21. Effect of high-dose corticosteroid therapy on blood flow, evoked potentials, and extracellular calcium in experimental spinal injury